Prognostic significance of p16 immunohistochemical expression in urothelial carcinoma

[1] Alexander RE(2012)p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma Mod Pathol 25 1526-1533

[2] Hu Y(2007)Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer J Surg Res 143 422-427

[3] Kum JB(1995)Frequency of homozygous deletion at p16/CDKN2 in primary human tumours Nat Genet 11 210-212

[4] Montironi R(1992)Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer J Natl Cancer Inst 84 1251-1256

[5] Lopez-Beltran A(2016)Prognostic and Clinicopathological significance of downregulated p16 expression in patients with bladder Cancer: a systematic review and meta-analysis Dis Markers 2016 5259602-467

[6] Maclennan GT(2018)Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis BMC Res Notes 11 207-100

[7] Idrees MT(2018)Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder BMC Urol 18 59-59

[8] Emerson RE(2005)P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma Eur Urol 47 463-1577

[9] Ulbright TM(2014)Diagnostic utility of p53 and CK20 immunohistochemical expression grading urothelial malignancies Int Arch Med 7 36-194

[10] Grignon DG(2006)p16(INK4a) expression in urinary bladder carcinoma Arch Ital Urol Androl 78 97-535

[1] Alexander RE(2012)p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma Mod Pathol 25 1526-1533

[2] Hu Y(2007)Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer J Surg Res 143 422-427

[3] Kum JB(1995)Frequency of homozygous deletion at p16/CDKN2 in primary human tumours Nat Genet 11 210-212

[4] Montironi R(1992)Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer J Natl Cancer Inst 84 1251-1256

[5] Lopez-Beltran A(2016)Prognostic and Clinicopathological significance of downregulated p16 expression in patients with bladder Cancer: a systematic review and meta-analysis Dis Markers 2016 5259602-467

[6] Maclennan GT(2018)Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis BMC Res Notes 11 207-100

[7] Idrees MT(2018)Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder BMC Urol 18 59-59

[8] Emerson RE(2005)P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma Eur Urol 47 463-1577

[9] Ulbright TM(2014)Diagnostic utility of p53 and CK20 immunohistochemical expression grading urothelial malignancies Int Arch Med 7 36-194

[10] Grignon DG(2006)p16(INK4a) expression in urinary bladder carcinoma Arch Ital Urol Androl 78 97-535